The DOD Directed Congressional Directed Medical Research Programs
Duration: January 1, 2008
to
present
General Issues: Defense , Health Issues , Medical/Disease Research/Clinical Labs
Spending: about $5,036,675 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2008: U.S. Senate, House of Representatives, Defense - Dept of (DOD), White House Office, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense Advanced Research Projects Agency (DARPA), Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Government Accountability Office (GAO), White House Office,
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on April 19.
Original Filing: 301565482.xml
Lobbying Issues
The DOD Directed Congressional Directed Medical Research Programs
4th Quarter, 2023
In Q4, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on Jan. 22.
Original Filing: 301540671.xml
Lobbying Issues
The DOD Directed Congressional Directed Medical Research Programs
3rd Quarter, 2023
In Q3, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on Oct. 20, 2023.
Original Filing: 301516517.xml
Lobbying Issues
The DOD Directed Congressional Directed Medical Research Programs
2nd Quarter, 2023
In Q2, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on July 20, 2023.
Original Filing: 301488661.xml
Lobbying Issues
The DOD Directed Congressional Directed Medical Research Programs
1st Quarter, 2023
In Q1, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on April 21, 2023.
Original Filing: 301468473.xml
Lobbying Issues
The DOD Directed Congressional Directed Medical Research Programs
4th Quarter, 2022
In Q4, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on Jan. 20, 2023.
Original Filing: 301441521.xml
Lobbying Issues
The DOD Directed Congressional Directed Medical Research Programs
3rd Quarter, 2022
In Q3, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on Oct. 20, 2022.
Original Filing: 301416896.xml
Lobbying Issues
The DOD Directed Congressional Directed Medical Research Programs
2nd Quarter, 2022
In Q2, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on July 20, 2022.
Original Filing: 301396374.xml
Lobbying Issues
The DOD Directed Congressional Directed Medical Research Programs
1st Quarter, 2022
In Q1, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on April 26, 2022.
Original Filing: 301373476.xml
Lobbying Issues
The DOD Directed Congressional Directed Medical Research Programs
4th Quarter, 2021
In Q4, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on Jan. 19, 2022.
Original Filing: 301329663.xml
Lobbying Issues
The DOD Directed Congressional Directed Medical Research Programs
3rd Quarter, 2021
In Q3, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on Oct. 19, 2021.
Original Filing: 301306088.xml
Lobbying Issues
The DOD Directed Congressional Directed Medical Research Programs
2nd Quarter, 2021
In Q2, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on July 19, 2021.
Original Filing: 301282909.xml
Lobbying Issues
The DOD Directed Congressional Directed Medical Research Programs
1st Quarter, 2021
In Q1, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on April 20, 2021.
Original Filing: 301267432.xml
Lobbying Issues
The DOD Directed Congressional Directed Medical Research Programs
Agencies Lobbied
U.S. Senate
4th Quarter, 2020
NATIONAL BREAST CANCER COALITION FUND amended a lobbying report for in-house lobbying in Q42020 on Feb. 17, 2021
Original Filing: 301248724.xml
Lobbying Issues
The DOD Directed Congressional Directed Medical Research Programs
Agencies Lobbied
U.S. Senate
4th Quarter, 2020
In Q4, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on Jan. 20, 2021.
Original Filing: 301239025.xml
Lobbying Issues
The DOD Directed Congressional Directed Medical Research Programs
Agencies Lobbied
U.S. Senate
3rd Quarter, 2020
In Q3, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on Oct. 28, 2020.
Original Filing: 301225493.xml
Lobbying Issues
The DOD Directed Congressional Directed Medical Research Programs
2nd Quarter, 2020
In Q2, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on July 17, 2020.
Original Filing: 301191447.xml
Lobbying Issues
The DOD Directed Congressional Directed Medical Research Programs
1st Quarter, 2020
In Q1, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on April 22, 2020.
Original Filing: 301180925.xml
Lobbying Issues
The DOD Directed Congressional Directed Medical Research Programs
4th Quarter, 2019
NATIONAL BREAST CANCER COALITION FUND amended a lobbying report for in-house lobbying in Q42019 on March 2, 2020
Original Filing: 301142703.xml
Lobbying Issues
The DOD Directed Congressional Directed Medical Research Programs
4th Quarter, 2019
In Q4, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on Jan. 8, 2020.
Original Filing: 301103780.xml
Lobbying Issues
The DOD Directed Congressional Directed Medical Research Programs
3rd Quarter, 2019
In Q3, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on Oct. 21, 2019.
Original Filing: 301077292.xml
Lobbying Issues
The DOD Directed Congressional Directed Medical Research Programs
2nd Quarter, 2019
NATIONAL BREAST CANCER COALITION FUND amended a lobbying report for in-house lobbying in Q22019 on July 19, 2019
Original Filing: 301052494.xml
Lobbying Issues
The DOD Directed Congressional Directed Medical Research Programs
2nd Quarter, 2019
In Q2, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on July 18, 2019.
Original Filing: 301049889.xml
Lobbying Issues
The DOD Directed Congressional Directed Medical Research Programs
1st Quarter, 2019
In Q1, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on May 8, 2019.
Original Filing: 301040604.xml
Lobbying Issues
The DOD Directed Congressional Directed Medical Research Programs
4th Quarter, 2018
NATIONAL BREAST CANCER COALITION FUND amended a lobbying report for in-house lobbying in Q42018 on Feb. 13, 2019
Original Filing: 301020278.xml
Lobbying Issues
The DOD Directed Congressional Directed Medical Research Programs.
4th Quarter, 2018
In Q4, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on Feb. 8, 2019.
Original Filing: 301020068.xml
Lobbying Issues
The DOD Directed Congressional Directed Medical Research Programs.
3rd Quarter, 2018
In Q3, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on Oct. 24, 2018.
Original Filing: 300999278.xml
Lobbying Issues
The DOD Congressional Directed Medical Research Programs.
2nd Quarter, 2018
In Q2, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on Aug. 10, 2018.
Original Filing: 300980547.xml
Lobbying Issues
The DOD Congressional Directed Medical Research Programs.
1st Quarter, 2018
In Q1, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists, and was paid $58,552. The report was filed on April 16, 2018.
Original Filing: 300945181.xml
Lobbying Issues
DEF-funding for the Department of Defense peer-reviewed Breast Cancer Research Program for fiscal year 2019.
HCR- funding for the Department of Defense peer-reviewed Breast Cancer Research Program for fiscal year 2019.
MED- funding for the Department of Defense peer-reviewed Breast Cancer Research Program for fiscal year 2019.
Agencies Lobbied
U.S. Senate
Lobbying Issues
funding for the Department of Defense peer-reviewed Breast Cancer Research Program for fiscal year 2019.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Disease Research/Clinical Labs
4th Quarter, 2017
In Q4, NATIONAL BREAST CANCER COALITION FUND did no lobbying for itself. The report was filed on May 15, 2018.
Original Filing: 300960217.xml
3rd Quarter, 2017
In Q3, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on Nov. 1, 2017.
Original Filing: 300918532.xml
Lobbying Issues
The DOD Congressionally Directed Medical Research Programs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR1628, the American Health Care Act. Reforming parts of the ACA.
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 1628, the American Health Care Act. Reforming parts of the ACA.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2017
In Q2, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on July 6, 2017.
Original Filing: 300882306.xml
Lobbying Issues
The DOD Congressionally Directed Medical Research Programs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR1628, the American Health Care Act. Reforming parts of the ACA.
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 1628, the American Health Care Act. Reforming parts of the ACA.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2017
In Q1, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on June 19, 2017.
Original Filing: 300881186.xml
Lobbying Issues
HR1628, the American Health Care Act. Reforming parts of the ACA.
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR1628, the American Health Care Act. Reforming parts of the ACA.
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 1628, the American Health Care Act. Reforming parts of the ACA.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2016
In Q4, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on June 19, 2017.
Original Filing: 300881183.xml
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Guaranteed Access to Quality Care for All; Medicaid Breast and Cervical Cancer Treatment Program; Health Care Reform; Issues and legislation related to the Breast Cancer Deadline 2020 goal of knowing how to end breast cancer by January 1, 2020.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Issues and legislation related to the Breast Cancer Deadline 2020 goal of knowing how to end breast cancer by January 1, 2020.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2016
In Q3, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on Oct. 20, 2016.
Original Filing: 300837782.xml
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Guaranteed Access to Quality Care for All; Medicaid Breast and Cervical Cancer Treatment Program; Health Care Reform; Issues and legislation related to the Breast Cancer Deadline 2020 goal of knowing how to end breast cancer by January 1, 2020.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Issues and legislation related to the Breast Cancer Deadline 2020 goal of knowing how to end breast cancer by January 1, 2020.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2016
In Q2, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on July 20, 2016.
Original Filing: 300820216.xml
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Guaranteed Access to Quality Care for All; Medicaid Breast and Cervical Cancer Treatment Program; Health Care Reform; Issues and legislation related to the Breast Cancer Deadline 2020 goal of knowing how to end breast cancer by January 1, 2020.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Issues and legislation related to the Breast Cancer Deadline 2020 goal of knowing how to end breast cancer by January 1, 2020.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2016
In Q1, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on April 20, 2016.
Original Filing: 300800797.xml
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Guaranteed Access to Quality Care for All; Medicaid Breast and Cervical Cancer Treatment Program; Health Care Reform; Issues and legislation related to the Breast Cancer Deadline 2020 goal of knowing how to end breast cancer by January 1, 2020.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Issues and legislation related to the Breast Cancer Deadline 2020 goal of knowing how to end breast cancer by January 1, 2020.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2015
In Q4, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on Jan. 20, 2016.
Original Filing: 300783114.xml
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Guaranteed Access to Quality Care for All; Medicaid Breast and Cervical Cancer Treatment Program; Health Care Reform; Issues and legislation related to the Breast Cancer Deadline 2020 goal of knowing how to end breast cancer by January 1, 2020.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Issues and legislation related to the Breast Cancer Deadline 2020 goal of knowing how to end breast cancer by January 1, 2020.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2015
In Q3, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on Oct. 19, 2015.
Original Filing: 300756398.xml
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Guaranteed Access to Quality Care for All; Medicaid Breast and Cervical Cancer Treatment Program; Health Care Reform; Issues and legislation related to the Breast Cancer Deadline 2020 goal of knowing how to end breast cancer by January 1, 2020.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Issues and legislation related to the Breast Cancer Deadline 2020 goal of knowing how to end breast cancer by January 1, 2020.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2015
NATIONAL BREAST CANCER COALITION FUND amended a lobbying report for in-house lobbying in Q22015 on July 14, 2015
Original Filing: 300733986.xml
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Guaranteed Access to Quality Care for All; Medicaid Breast and Cervical Cancer Treatment Program; Health Care Reform; Issues and legislation related to the Breast Cancer Deadline 2020 goal of knowing how to end breast cancer by January 1, 2020.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Issues and legislation related to the Breast Cancer Deadline 2020 goal of knowing how to end breast cancer by January 1, 2020.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2015
In Q2, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on July 9, 2015.
Original Filing: 300732507.xml
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Guaranteed Access to Quality Care for All; Medicaid Breast and Cervical Cancer Treatment Program; Health Care Reform; Issues and legislation related to the Breast Cancer Deadline 2020 goal of knowing how to end breast cancer by January 1, 2020.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Issues and legislation related to the Breast Cancer Deadline 2020 goal of knowing how to end breast cancer by January 1, 2020.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2015
In Q1, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on April 17, 2015.
Original Filing: 300719780.xml
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Guaranteed Access to Quality Care for All; Medicaid Breast and Cervical Cancer Treatment Program; Health Care Reform; Issues and legislation related to the Breast Cancer Deadline 2020 goal of knowing how to end breast cancer by January 1, 2020.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Issues and legislation related to the Breast Cancer Deadline 2020 goal of knowing how to end breast cancer by January 1, 2020.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2014
In Q4, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on Jan. 15, 2015.
Original Filing: 300696983.xml
Lobbying Issues
Funding for peer-reviewed Brest Cancer Research Program
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Guaranteed Access to Quality Care for All; Medicaid Breast and Cervical Cancer Treatment Program; Health Care Reform; Issues and legislation related to the Breast Cancer Deadline 2020 goal of knowing how to end breast cancer by January 1, 2020.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Disease Research/Clinical Labs
3rd Quarter, 2014
In Q3, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on Oct. 17, 2014.
Original Filing: 300680789.xml
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Guaranteed Access to Quality Care for All; Medicaid Breast and Cervical Cancer Treatment Program; Health Care Reform; Issues and legislation related to Breast Cancer Deadline 2020 goal of knowing how to end breast cancer by January 1, 2020.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for DOD peer reviewed Breast Cancer Research Program; Issues and legislation related to Breast Cancer Deadline 2020 goal of knowing how to end breast cancer by January 1, 2020.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2014
In Q2, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on July 21, 2014.
Original Filing: 300664752.xml
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Guaranteed Access to Quality Care for All; Medicaid Breast and Cervical Treatment Program; Health Care Reform; Issues and legislation related to Breast Cancer Deadline 2020 goal of knowing how to end breast cancer by January 1, 2020.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for DOD peer reviewed Breast Cancer Research Program; Issues and legislation related to Breast Cancer Deadline 2020 goal of knowing how to end breast cancer by January 1, 2020.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2014
In Q1, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on April 18, 2014.
Original Filing: 300641470.xml
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Guaranteed Access to Quality Care for All; Medicaid Breast and Cervical Treatment Program; Health Care Reform; Issues and legislation related to Breast Cancer Deadline 2020 goal of knowing how to end breast cancer by January 1, 2020.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for DOD peer reviewed Breast Cancer Research Program; Issues and legislation related to Breast Cancer Deadline 2020 goal of knowing how to end breast cancer by January 1, 2020.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2013
In Q4, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on Jan. 22, 2014.
Original Filing: 300628285.xml
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Guaranteed Access to Quality Care for All; Medicaid Breast and Cervical Treatment Program; Health Care Reform; Issues and legislation related to Breast Cancer Deadline 2020 goal of knowing how to end breast cancer by January 1, 2020.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for DOD peer reviewed Breast Cancer Research Program; Issues and legislation related to Breast Cancer Deadline 2020 goal of knowing how to end breast cancer by January 1, 2020.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2013
In Q3, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on Oct. 21, 2013.
Original Filing: 300602300.xml
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Guaranteed Access to Quality Care for All; Medicaid Breast and Cervical Cancer Treatment Program; Health Care Reform; Issues and legislation related to Breast Cancer Deadline 2020 goal of ending breast cancer by January 1, 2020.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for DOD peer-reviewed Breast Cancer Research Program; Issues and legislation related to the Breast Cancer 2020 goal of ending breast cancer by January 1, 2020.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2013
In Q2, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on July 22, 2013.
Original Filing: 300581278.xml
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Guaranteed Access to Quality Care for All; Medicaid Breast and Cervical Cancer Treatment Program; Health Care Reform; Issues and legislation related to Breast Cancer 2020 goal of ending breast cancer by January 1, 2020.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Issues and legislation related to the Breast Cancer 2020 goal of ending breast cancer by January 1, 2020
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2013
In Q1, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on April 19, 2013.
Original Filing: 300556443.xml
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Guaranteed Access to Quality Care for All; Medicaid Breast and Cervical Cancer Treatment Program; Health Care Reform; Issues and legislation related to the Breast Cancer 2020 goal of ending breast cancer by January 1, 2020.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Issues and legislation related to the Breast Cancer 2020 goal of ending breast cancer by January 1, 2020.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2012
In Q4, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on Jan. 22, 2013.
Original Filing: 300539682.xml
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Guaranteed Access to Quality Care for All; Medicaid Breast and Cervical Cancer Treatment Program; Health Care Reform; Issues and Legislation related to the Breast Cancer 2020 goal of ending breast cancer by January 1, 2020.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Issues and legislation related to the Breast Cancer Deadline 2020 goal of ending breast cancer by January 1, 2020.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2012
In Q3, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on Oct. 19, 2012.
Original Filing: 300512454.xml
Lobbying Issues
Funding for the DOD peer reviewed Breast Cancer Research Program
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Guaranteed Access to Quality Care for All; Breast and Cervical Cancer Treatment Program; Health Care Reform; Issues and Legislation related to the Breast Cancer Deadline 2020 goal of ending breast cancer by January 1, 2020.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Issues and legislation related to the Breast Cancer Deadline 2020 goal of ending breast cancer by January 1, 2020.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2012
In Q2, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on July 20, 2012.
Original Filing: 300494772.xml
Lobbying Issues
Funding for the DOD peer reviewed Breast Cancer Research Program
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Guaranteed Access to Quality Care for All; Breast and Cervical Cancer Treatment Program; Health Care Reform; Issues and legislation related to the Breast Cancer Deadline 2020 goal of ending breast cancer by January 1, 2020.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Issues and legislation related to the Breast Cancer Deadline 2020 goal of ending breast cancer by January 1, 2020.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2012
In Q1, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on April 20, 2012.
Original Filing: 300469567.xml
Lobbying Issues
Funding for the DOD peer reviewed Breast Cancer Research Program
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DOD peer reviewed Breast Cancer Research Program; Guaranteed Access to Quality Care for All; Breast and Cervical Cancer Treatment Program; Health Care Reform; Issues and legislation related to the Breast Cancer Deadline 2020 goal of ending breast cancer by January 1, 2020.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for DOD peer reviewed Breast Cancer Research Program; Issues and legislation related to the Breast Cancer Deadline 2020 goal of ending breast cancer by January 1, 2020.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2011
In Q4, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on Jan. 20, 2012.
Original Filing: 300450813.xml
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Guaranteed Access to Quality Care for All; Breast and Cervical Cancer Treatment Program; Health Care Reform; Enactment of H.R. 3067, Accelerating the End of Breast Cancer Act; and issues related to the Breast Cancer Deadline 2020 goal of ending breast cancer by January 1, 2020.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Enactment of H.R. 3067, Accelerating the End of Breast Cancer Act; and issues related to the Breast Cancer Deadline 2020 goal of ending breast cancer by January 1, 2020.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2011
In Q3, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on Oct. 20, 2011.
Original Filing: 300422830.xml
Lobbying Issues
Funding for the DOD peer-reveiewed Breast Cancer Research Program
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Guaranteed Access to Quality Care for All; Breast and Cervical Cancer Treatment Program; Health Care Reform; Enactment of H.R. 3067, Accelerating the End of Breast Cancer Act; and issues related to Breast Cancer Deadline goal of ending breast cancer by January 1, 2020.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DOD peer reviewed Breast Cancer Research Program; Enactment of H.R. 3067, Accelerating the End of Breast Cancer Act; and issues related to Breast Cancer Deadline goal of ending breast cancer by January 1, 2020.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2011
In Q2, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on July 19, 2011.
Original Filing: 300394809.xml
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program; Guaranteed Access to Quality Care for All; Breast and Cervical Cancer Treatment Program; Health Care Reform; Issues related to Breast Cancer Deadline 2020 goal of ending breast cancer by January 1, 2020
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for DOD peer reviewed Breast Cancer Research Program; Issues related to Breast Cancer Deadline 2020 goal of ending breast cancer by January 1, 2020
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2011
In Q1, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on April 19, 2011.
Original Filing: 300371373.xml
Lobbying Issues
Funding for the DOD peer reviewed Breast Cancer Research Program
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for DOD peer reviewed Breast Cancer Research Program, Guaranteed Access to Quality Care for All; Breast and Cervical Cancer Treatment Program; Health Care Reform; Issues related to Breast Cancer Deadline 2020 goal of ending breast cancer by January 1, 2020
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for DOD peer reviewed Breast Cancer Research Program; Issues related to Breast Cancer Deadline 2020 goal of ending breast cancer by January 1, 2020
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2010
In Q4, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on Jan. 19, 2011.
Original Filing: 300346354.xml
Lobbying Issues
Funding for the DOD peer-reviewed Breast Cancer Research Program
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DOD peer reviewed Breast Cancer Research Program, Guaranteed Access to Quality Care for All; Breast and Cervical Cancer Treatment Program; Health Care Reform; Issues related to Ending Breast Cancer by 2020
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DOD peer reviewed Breast Cancer Research Program; Issues relating to Ending Breast Cancer by 2020
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2010
In Q3, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on Oct. 20, 2010.
Original Filing: 300324389.xml
Lobbying Issues
Funding for the DoD peer-reviewed Breast Cancer Research Program
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DoD Peer Reviewed Breast Cancer Research Program; Guranteed Access to Quality Care for All; Breast and Cervical Cancer Treatment Program; Health Care Reform; Issues relating to Eradicating Breast Cancer by 2010
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DoD peer-reviewed Breast Cancer Research Program; Issues relating to Eradicating Breast Cancer by 2010
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2010
In Q2, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on July 20, 2010.
Original Filing: 300299606.xml
Lobbying Issues
Funding for the DoD peer-reviewed Breast Cancer Research Program
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DoD peer-reviewed Breast Cancer Research Program; Guaranteed Access to Quality Care for All; Breast and Cervical Cancer Treatment Program; Health Care Reform
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DoD peer-reviewed Breast Cancer Research Program
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2010
In Q1, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on April 19, 2010.
Original Filing: 300265130.xml
Lobbying Issues
Funding for the DoD peer-reviewed Breast Cancer Research Program
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DoD peer-reviewed Breast Cancer Research Program; Guaranteed Access to Quality Care for All; Breast and Cervical Cancer Treatment Program; Health Care Reform
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DoD peer-reviewed Breast Cancer Research Program
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2009
In Q4, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on Jan. 16, 2010.
Original Filing: 300233573.xml
Lobbying Issues
Funding for the DoD peer-reviewed Breast Cancer Research Program
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DoD peer-reviewed Breast Cancer Research Program; Guaranteed Access to Quality Care for All; Breast and Cervical Cancer Treatment Program
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DoD peer-reviewed Breast Cancer Research Program
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2009
In Q3, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on Oct. 19, 2009.
Original Filing: 300209220.xml
Lobbying Issues
Funding for the DoD peer-reviewed Breast Cancer Research Program
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DoD peer-reviewed Breast Cancer Research Program; Guaranteed Access to Quality Care for All; Breast and Cervical Cancer Treatment Program
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DoD peer-reviewed Breast Cancer Research Program
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2009
NATIONAL BREAST CANCER COALITION FUND amended a lobbying report for in-house lobbying in Q22009 on Oct. 19, 2009
Original Filing: 300209316.xml
Lobbying Issues
Funding for the DoD peer-reviewed Breast Cancer Research Program
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DoD peer-reviewed Breast Cancer Research Program; Guaranteed Access to Quality Care for All; Breast and Cervical Cancer Treatment Program
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DoD peer-reviewed Breast Cancer Research Program
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2009
In Q2, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on July 16, 2009.
Original Filing: 300180907.xml
Lobbying Issues
Funding for the DoD peer-reviewed Breast Cancer Research Program
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DoD peer-reviewed Breast Cancer Research Program; Guaranteed Access to Quality Care for All; Breast and Cervical Cancer Treatment Program
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DoD peer-reviewed Breast Cancer Research Program
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2009
In Q1, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on April 20, 2009.
Original Filing: 300161549.xml
Lobbying Issues
Funding for the DoD peer-reviewed Breast Cancer Research Program
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DoD peer-reviewed Breast Cancer Research Program; Guaranteed Access to Quality Care for All; Breast and Cervical Cancer Treatment Program
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DoD peer-reviewed Breast Cancer Research Program
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2008
In Q4, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on Jan. 21, 2009.
Original Filing: 300133405.xml
Lobbying Issues
Funding for the DoD peer-reviewed Breast Cancer Research Program
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DoD peer-reviewed Breast Cancer Research Program; Enactment of S579/HR1157 The Breast Cancer and Environmental Research Act; Guaranteed Access to Quality Care for All; Breast and Cervical Cancer Treatment Program
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DoD peer-reviewed Breast Cancer Research Program; Enactment of S579/HR1157 The Breast Cancer and Environmental Research Act
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2008
NATIONAL BREAST CANCER COALITION FUND amended a lobbying report for in-house lobbying in Q32008 on Oct. 25, 2011
Original Filing: 300430835.xml
Lobbying Issues
Funding for the DOD Breast Cancer Research Program of $150 million in FY09
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DOD Breast Cancer Research Program of $150 million for FY09
Enactment of H.R.1157/S.579, the Breast Cancer and Environmental Research Act
Guaranteed Access to Quality Health Care for All
Preservation of the Breast and Cervical Cancer Treatment Program
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DOD Breast Cancer Research Program of $150 million for FY09
Enactment of the S.579/H.R.1157, the Breast Cancer and Environmental Research Act
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2008
In Q3, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on Oct. 17, 2008.
Original Filing: 300098549.xml
Lobbying Issues
Funding for the DOD Breast Cancer Research Program of $150 million in FY09
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DOD Breast Cancer Research Program of $150 million for FY09
Enactment of H.R.1157/S.579, the Breast Cancer and Environmental Research Act
Guaranteed Access to Quality Health Care for All
Preservation of the Breast and Cervical Cancer Treatment Program
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Funding for the DOD Breast Cancer Research Program of $150 million for FY09
Enactment of the S.579/H.R.1157, the Breast Cancer and Environmental Research Act
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2008
In Q2, NATIONAL BREAST CANCER COALITION FUND had in-house lobbyists. The report was filed on July 21, 2008.
Original Filing: 300082226.xml
Lobbying Issues
Department of Defense Breast Cancer Research Program -- FY09 Appropriations
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Department of Defense Breast Cancer Research Program -- FY09 Appropriations
S.579/H.R.1157 Breast Cancer and Environmental Research Act -- enactment
Guaranteed Access to Quality Care for All -- general health issues, no specific legislation
Breast and Cervical Cancer Treatment Program
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
DOD Breast Cancer Research Program - FY09 Appropriations
S.579/H.R.1157 Breast Cancer and Environmental Research Act -- enactment
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2008
In Q1, NATIONAL BREAST CANCER COALITION had in-house lobbyists. The report was filed on April 17, 2008.
Original Filing: 300041142.xml
Lobbying Issues
Funding for the DOD Breast Cancer Research Program FY09 appropriations
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
DOD Breast Cancer Research Program - FY09 Appropriations
S.579/H.R.1157, Breast Cancer and Environmental Research Act - enactment
Guaranteed Access to Quality Health Care for All -- general health care issues, no specific legislation
Breast and Cervical Cancer Treatment Program
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
DOD Breast Cancer Research Program - FY09 Appropriations
S.579/H.R.1157, Breast Cancer and Environmental Research Act - enactment
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...